Moreover, we also showed that this treatment resulted in marked changes in NUP98::NSD1-driven transcriptional networks that also included the downregulation of FLT3-ITD, which is a very common mutation in NUP98-r AML. This evidence concerns the gene NSD1 and acute myeloid leukemia.